top of page
gradientForSurfBreak.png

Item List

Sep 25, 2024
Contract Pharma
Cytiva, Pear Bio Partner on Personalized Cancer Medicine

Cytiva, a global life sciences company, and Pear Bio, a pioneer in personalized cancer medicine, are collaborating to advance cancer research and personalized treatment. Pear Bio is using Cytiva’s Via Extractor technology to create dissociated tumor cell suspensions with high viability and yield, revolutionizing tumor cell analysis.

Recent Posts

Portfolio Company

Carlsmed.png

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinica ...

Businesswire

Apr 30, 2026

Portfolio Company

Carlsmed.png

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectr ...

BioSpace

Apr 16, 2026

Portfolio Company

Carlsmed.png

The most innovative healthcare companies of 2026 ...

Fast Company

Mar 24, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page